Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters.
Ritter Z, Papp L, Zámbó K, Tóth Z, Dezső D, Veres DS, Máthé D, Budán F, Karádi É, Balikó A, Pajor L, Szomor Á, Schmidt E, Alizadeh H.
Ritter Z, et al. Among authors: budan f.
Front Oncol. 2022 Jun 8;12:820136. doi: 10.3389/fonc.2022.820136. eCollection 2022.
Front Oncol. 2022.
PMID: 35756658
Free PMC article.